Thoracic Surgery Devices Market Size & Growth Forecast 2027–2036, By Segments (End-use, Surgery Type, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Thoracic Surgery Devices Market size stood at USD 818.2 million in 2026 and is predicted to grow at a 6.1% CAGR from 2027 to 2036, surpassing USD 1.48 billion by 2036. The industry revenue for 2027 is calculated at USD 860.22 million.
Get more details on this report
Request Free Sample ReportThoracic Surgery Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 41.20% of the market in 2026, supported by advanced surgical infrastructure, widespread minimally invasive procedures, and strong adoption of device-intensive thoracic interventions.
- Asia Pacific is projected to grow at a 7.35% CAGR as hospitals modernize, surgical access expands, and providers increasingly adopt advanced thoracic procedures and specialized devices.
Segment Momentum
- Hospitals held a 48.65% share in 2026 because they provide advanced operating infrastructure, multidisciplinary surgical teams, and critical postoperative care required for complex thoracic procedures.
- Wedge resection is the fastest-growing surgery type as demand increases for tissue-sparing procedures that preserve lung function while treating localized abnormalities through less invasive approaches.
Market Expansion Drivers
- Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery.
- Adoption of minimally invasive and robotic-assisted thoracic surgical techniques.
- Expanding outpatient surgical procedures increasing demand for precision thoracic instruments.
Leading Market Participants
- Top players in the thoracic surgery devices market include Medtronic plc (Ireland), Intuitive Surgical, Inc. (United States), Teleflex Incorporated (United States), Richard Wolf GmbH (Germany), LivaNova PLC (United Kingdom), Medela Holding AG (Switzerland), Sklar Surgical Instruments (United States), Cardio Medical GmbH (Germany), Grena Ltd. (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 818.2 million
- 2027 Estimated Market Size: USD 860.22 million.
- Projected Market Size: USD 1.48 billion by 2036
- Growth Forecast: 6.1% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Lobectomy (Surgery Type) | Forceps (Product)
- Emerging Opportunity Segment: Ambulatory Surgical Centers (End-use) | Wedge Resection (Surgery Type) | Staplers (Product)
Market Growth Drivers and Industry Trends
Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery
The aging population will drive the thoracic surgery devices market growth as the incidence of lung and cardiac thoracic conditions rises among older patients, increasing the need for surgical intervention. This demographic shift expands the pool of patients requiring thoracic procedures and supports demand for devices used across surgical treatment pathways for these conditions.
Adoption of minimally invasive and robotic-assisted thoracic surgical techniques
Growing adoption of minimally invasive and robotic-assisted procedures will propel the thoracic surgery devices market by increasing the need for specialized instruments and technologies that support greater procedural precision. As surgical techniques evolve toward these approaches, healthcare providers require devices compatible with advanced thoracic procedures and their associated operating requirements.
Expanding outpatient surgical procedures increasing demand for precision thoracic instruments
The thoracic surgery devices market growth is supported by the expansion of outpatient surgical procedures, which is increasing demand for precision instruments suited to controlled and efficient thoracic interventions. Greater use of outpatient settings places emphasis on accurate surgical tools that can support thoracic procedures while meeting the procedural requirements of these care environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing thoracic surgeries and procedural demand | 2.50% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Technological advancement in thoracic surgery devices | 2.00% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Expansion of surgical centers and minimally invasive interventions | 2.00% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Aging population increasing incidence of lung and cardiac thoracic conditions requiring surgery | 2.10% | Moderate | North America, Europe | High | Near Term |
| Adoption of minimally invasive and robotic-assisted thoracic surgical techniques | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expanding outpatient surgical procedures increasing demand for precision thoracic instruments | 1.40% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the thoracic surgery devices market, North America held the largest share of 41.20% in 2026, supported by advanced surgical infrastructure, widespread adoption of minimally invasive procedures, and strong demand for sophisticated devices used in thoracic interventions. The region benefits from well-established healthcare systems with high access to specialized surgical facilities and experienced clinical professionals. Increasing preference for procedures that can reduce tissue trauma, shorten recovery periods, and improve surgical precision is encouraging the adoption of advanced thoracic surgical technologies. In addition, sustained investment in hospital modernization, clinical research, and surgical technology is strengthening the availability and utilization of specialized devices. A growing burden of thoracic conditions and the increasing emphasis on early diagnosis and effective intervention are also contributing to demand, while favorable reimbursement structures and established pathways for introducing medical technologies support continued market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth in the thoracic surgery devices market, driven by expanding healthcare infrastructure, improving access to specialized surgical care, and rising healthcare expenditure across emerging economies. The region is witnessing greater investment in hospitals and advanced operating facilities, creating opportunities for broader adoption of modern thoracic surgical technologies. Growing awareness of minimally invasive treatment options among patients and healthcare providers is also supporting demand for sophisticated surgical devices. At the same time, an expanding patient population, increasing prevalence of respiratory and thoracic disorders, and improvements in specialist training are encouraging the development of more capable surgical ecosystems. Government initiatives aimed at strengthening healthcare accessibility, combined with the gradual adoption of advanced medical technologies in urban and developing healthcare centers, are expected to reinforce the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Surgical Precision FocusGermany emphasizes thoracic surgery devices engineered for precision, reliability, and integration with advanced operating room technologies. Clinical adoption centers on improving procedural efficiency and supporting specialized thoracic and cardiothoracic surgical practices.
France 🇫🇷
Specialized Procedure SupportFrance prioritizes thoracic surgery devices that meet the needs of specialized surgical centers managing complex pulmonary and thoracic conditions. Clinical purchasing decisions emphasize dependable performance, ergonomic design, and compatibility with minimally invasive techniques.
Italy 🇮🇹
Hospital Technology EnhancementItaly expands investment in thoracic surgery devices that improve surgical efficiency and support minimally invasive treatment approaches. Italian healthcare providers value versatile instruments that integrate effectively into modern operating rooms and specialized thoracic care pathways.
Japan 🇯🇵
Advanced Clinical IntegrationJapan strengthens use of thoracic surgery devices through integration with advanced imaging, minimally invasive techniques, and specialized surgical workflows. Healthcare providers focus on improving procedural accuracy while supporting better patient recovery.
South Korea 🇰🇷
Robotic Surgery AdoptionSouth Korea increasingly incorporates thoracic surgery devices into robotic-assisted and video-assisted surgical procedures. Hospitals invest in advanced instrumentation that enhances precision, workflow efficiency, and treatment quality for thoracic disease management.
United States 🇺🇸
Minimally Invasive AdvancementU.S. hospitals continue adopting thoracic surgery devices that support minimally invasive and robotic-assisted procedures. Healthcare providers prioritize technologies that improve surgical precision, reduce recovery times, and enhance outcomes in complex thoracic interventions.
Segment Leadership and Growth Trends
Thoracic Surgery Devices Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals dominated the thoracic surgery devices market, accounting for a 48.65% share in 2026, owing to their ability to manage complex thoracic procedures that require advanced surgical infrastructure, specialized teams, and comprehensive postoperative care. Hospitals remain central to the treatment of serious pulmonary and thoracic conditions because they can provide integrated diagnostic, surgical, intensive-care, and rehabilitation services. The availability of sophisticated operating facilities and multidisciplinary expertise therefore continues to support strong utilization of thoracic surgery devices in hospital settings.
Ambulatory surgical centers are gaining momentum as the fastest-growing end-use segment, supported by the increasing shift toward less invasive procedures and more efficient surgical care models. Advances in surgical techniques and device technologies are enabling selected thoracic interventions to be performed with shorter recovery requirements and reduced reliance on prolonged hospitalization. As healthcare providers seek to improve operating efficiency and patients increasingly favor convenient treatment settings, ambulatory centers are becoming more relevant for appropriate thoracic procedures.
Surgery Type Segment Analysis: Lobectomy (Largest Segment) vs Wedge Resection (Fastest-Growing Segment)
In the thoracic surgery devices market, the lobectomy segment held the largest share of 45.79% in 2026, reflecting its established role in the surgical management of localized lung conditions, particularly when removal of an affected lung lobe is clinically appropriate. The procedure benefits from mature surgical techniques and the continued use of specialized instruments designed to support tissue dissection, vessel management, and resection. Increasing emphasis on effective surgical treatment and improvements in minimally invasive approaches further support demand for devices used during lobectomy procedures.
Wedge resection is the fastest-growing surgery type as clinicians increasingly consider tissue-sparing approaches for suitable patients. The procedure removes a smaller portion of lung tissue and can be advantageous when preserving greater lung function is clinically important. Its relevance is being reinforced by advances in minimally invasive thoracic surgery, improved visualization, and the broader adoption of techniques designed to reduce surgical trauma and support faster recovery.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Surgery Type | Lobectomy, Wedge Resection, Pneumonectomy, Others | Lobectomy | Wedge Resection |
| Product | Clamps, Forceps, Graspers, Staplers, Scissors, Spreaders, Needle Holders, Others | Forceps | Staplers |
Competitive Landscape and Market Positioning
Major players in the thoracic surgery devices market:
1. Medtronic plc (Ireland)
2. Intuitive Surgical Inc. (United States)
3. Teleflex Incorporated (United States)
4. Richard Wolf GmbH (Germany)
5. LivaNova PLC (United Kingdom)
6. Medela Holding AG (Switzerland)
7. Sklar Surgical Instruments (United States)
8. Cardio Medical GmbH (Germany)
9. Grena Ltd. (United Kingdom)
Continuous innovation in minimally invasive procedures is advancing the thoracic surgery devices market, with research focused on robotic-assisted systems, enhanced visualization, and precision surgical instruments. These technological developments are improving surgical efficiency, patient safety, and postoperative recovery outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Intuitive Surgical Inc. (United States) | |||||||
| Teleflex Incorporated (United States) | |||||||
| Richard Wolf GmbH (Germany) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Medela Holding AG (Switzerland) | |||||||
| Sklar Surgical Instruments (United States) | |||||||
| Cardio Medical GmbH (Germany) | |||||||
| Grena Ltd. (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Johnson & Johnson | Jun-25 | Johnson & Johnson launched the ETHICON 4000 Stapler in the U.S., designed to address complex tissue handling and improve staple line integrity. The device aims to reduce surgical leaks and bleeding risks across procedures, strengthening the company’s advanced surgical portfolio in thoracic and minimally invasive surgery applications. |
| Intuitive Surgical | Apr-25 | Intuitive Surgical received U.S. FDA approval for the SP SureForm 45 stapler compatible with the da Vinci SP system. The device enhances wristed articulation and procedural precision in minimally invasive thoracic, colorectal, and urologic surgeries, reinforcing the company’s robotic-assisted surgery ecosystem and expanding its advanced stapling capabilities. |
| Olympus Corporation | Mar-25 | Olympus Corporation launched an AI-powered clinical decision support tool through a partnership with Ziosoft. The solution enhances surgical planning and clinical decision-making capabilities, strengthening Olympus’s digital transformation strategy and expanding its role in AI-enabled medical technologies for improved surgical outcomes. |
| Johnson & Johnson | Jul-24 | Johnson & Johnson introduced the ECHELON 3000 Stapler, a digitally enabled surgical device designed to improve precision, articulation range, and staple line control. The system enhances laparoscopic surgical efficiency and strengthens the company’s minimally invasive surgery portfolio with advanced digital and ergonomic capabilities. |
| Prana Thoracic, Inc. | Mar-23 | Prana Thoracic, Inc. secured USD 3 million in Series A funding to advance development of thoracic surgical technologies. The financing supports R&D activities aimed at improving surgical device innovation and accelerating commercialization efforts within minimally invasive thoracic procedures, strengthening the company’s position in the emerging surgical devices landscape. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Thoracic Surgery Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Surgical Approach | Open Surgery, Video-Assisted Thoracic Surgery, Robotic-Assisted Thoracic Surgery |
| Energy Modality | Electrosurgical, Ultrasonic, Advanced Bipolar, Mechanical |
| Procurement Type | Direct Purchase, Group Purchasing Organization, Distributor-Mediated Procurement |
Thoracic Surgery Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Minimally Invasive Thoracic Surgery Transformation |
|
| Hospital Capital Investment Priorities |
|
| Emerging Surgical Techniques and Technology Impact |
|
Need a different cut of the data?
Request Custom ResearchHow much is the thoracic surgery devices market worth?
How is the thoracic surgery devices industry projected to perform over the next decade?
How is the shift toward minimally invasive thoracic procedures influencing device procurement strategies?
Why are ambulatory surgical centers gaining importance in thoracic surgery device adoption?
Why are hospitals the largest end-use segment in the thoracic surgery devices market?
Which surgery type is growing the fastest in the thoracic surgery devices market?
Why does North America lead the thoracic surgery devices market?
What is driving thoracic surgery devices market growth in Asia Pacific?
What are the key competitors in the thoracic surgery devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization